These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 7964616

  • 1. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C, Haiss P, Grässer FA, Zimber-Strobl U, Mueller-Lantzsch N.
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [Abstract] [Full Text] [Related]

  • 2. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B, Sample CE.
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ, Crawford DH, Thomas JA.
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [Abstract] [Full Text] [Related]

  • 4. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD.
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C, Brooks AJ, Forshell LP, Yakimchuk K, Zhao B, Fulgham TZ, Sample CE.
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [Abstract] [Full Text] [Related]

  • 6. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Nov; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 7. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW.
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [Abstract] [Full Text] [Related]

  • 8. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G.
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R, Moses SC, Tan J, Kremmer E, Ling PD.
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [Abstract] [Full Text] [Related]

  • 14. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T, Sjöblom A, Masucci MG, Rymo L.
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas.
    Chen F, Hu LF, Ernberg I, Klein G, Winberg G.
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():131-8. PubMed ID: 7844522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.